Gomekli is part of the MEK Inhibitors class and treats Neurofibromatosis. MEK (mitogen activated protein kinase) inhibitors are used to treat certain types of cancers such as melanoma and lung cancer as well as neurofibromatosis. MEK inhibitors work by slowing tumor cell growth to prevent the spread of disease. Gomekli is only available as a brand name drug.